Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients
Clinical trial NCT02628132 · COMPLETED
Trial details
- NCT number
- NCT02628132
- Sponsor
- King Faisal Specialist Hospital & Research Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2019-12-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.